Annika Lundbåck

401 total citations
10 papers, 338 citations indexed

About

Annika Lundbåck is a scholar working on Microbiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Annika Lundbåck has authored 10 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Microbiology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Annika Lundbåck's work include Reproductive tract infections research (3 papers), Biochemical and Molecular Research (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Annika Lundbåck is often cited by papers focused on Reproductive tract infections research (3 papers), Biochemical and Molecular Research (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Annika Lundbåck collaborates with scholars based in Sweden and Canada. Annika Lundbåck's co-authors include Kurt Nordström, Lewis C. Ingram, Judy Gnarpe, H Gnarpe and Bo Sundelöf and has published in prestigious journals such as Journal of Bacteriology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Annika Lundbåck

10 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annika Lundbåck Sweden	9	132	111	110	105	69	10	338
B Lányi Hungary	10	142 1.1×	78 0.7×	46 0.4×	101 1.0×	87 1.3×	32	344
Christine Libon France	13	136 1.0×	130 1.2×	32 0.3×	29 0.3×	15 0.2×	16	417
Roderick Allan Lawson United Kingdom	3	151 1.1×	74 0.7×	39 0.4×	19 0.2×	39 0.6×	4	333
Howard Todd United Kingdom	8	98 0.7×	195 1.8×	125 1.1×	31 0.3×	13 0.2×	9	439
Zhao Wei China	5	137 1.0×	67 0.6×	53 0.5×	26 0.2×	141 2.0×	14	354
Nikhil N Kulkarni United States	11	120 0.9×	63 0.6×	108 1.0×	17 0.2×	63 0.9×	15	382
Elaine M. Mokrzan United States	10	145 1.1×	100 0.9×	118 1.1×	54 0.5×	23 0.3×	15	394
Laurel B. Kartchner United States	8	165 1.3×	67 0.6×	30 0.3×	30 0.3×	43 0.6×	10	340
Lauren J. McAllister Australia	9	107 0.8×	176 1.6×	88 0.8×	42 0.4×	45 0.7×	11	397
Vicky Sender Sweden	10	88 0.7×	197 1.8×	54 0.5×	14 0.1×	29 0.4×	14	384

Countries citing papers authored by Annika Lundbåck

Since Specialization

Citations

This map shows the geographic impact of Annika Lundbåck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Lundbåck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Lundbåck more than expected).

Fields of papers citing papers by Annika Lundbåck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Lundbåck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Lundbåck. The network helps show where Annika Lundbåck may publish in the future.

Co-authorship network of co-authors of Annika Lundbåck

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Lundbåck. A scholar is included among the top collaborators of Annika Lundbåck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Lundbåck. Annika Lundbåck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Gnarpe, Judy, et al.. (2000). Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae. Apmis. 108(12). 819–824. 18 indexed citations

Gnarpe, Judy, et al.. (2000). Serological analysis of specific IgA to Chlamydia pneumoniae: increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration. Apmis. 108(5). 357–362. 16 indexed citations

Gnarpe, Judy, Annika Lundbåck, H Gnarpe, & Bo Sundelöf. (1997). Comparison of nasopharyngeal and throat swabs for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae by polymerase chain reaction.. PubMed. 104. 11–2. 25 indexed citations

Lundbåck, Annika, et al.. (1994). Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections. Acta Paediatrica. 83(11). 1143–1145. 14 indexed citations

Gnarpe, Judy, Annika Lundbåck, Bo Sundelöf, & H Gnarpe. (1992). Prevalence of Mycoplasma pneumoniae in Subjectively Healthy Individuals¹. Scandinavian Journal of Infectious Diseases. 24(2). 161–164. 64 indexed citations

Gnarpe, H, et al.. (1984). Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791. Antimicrobial Agents and Chemotherapy. 25(2). 179–181. 12 indexed citations

Gnarpe, H, et al.. (1984). The in-vitro influence of ceftazidime on host defence mechanisms. Journal of Antimicrobial Chemotherapy. 13(4). 369–375. 6 indexed citations

Lundbåck, Annika & Kurt Nordström. (1974). Mutations in Escherichia coli K-12 Decreasing the Rate of Streptomycin Uptake: Synergism with R-Factor-Mediated Capacity to Inactivate Streptomycin. Antimicrobial Agents and Chemotherapy. 5(5). 500–507. 14 indexed citations

Lundbåck, Annika & Kurt Nordström. (1974). Effect of R-Factor-Mediated Drug-Metabolizing Enzymes on Survival of Escherichia coli K-12 in Presence of Ampicillin, Chloramphenicol, or Streptomycin. Antimicrobial Agents and Chemotherapy. 5(5). 492–499. 13 indexed citations

10.

Nordström, Kurt, Lewis C. Ingram, & Annika Lundbåck. (1972). Mutations in R Factors ofEscherichia coliCausing an Increased Number of R-Factor Copies per Chromosome. Journal of Bacteriology. 110(2). 562–569. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact